Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.
about
How to handle mortality when investigating length of hospital stay and time to clinical stabilityUse of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillationIntroduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation.Modeling cumulative incidence function for competing risks data.Statistical analysis of arthroplasty register dataFactors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrImpact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrosOverestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.Analyzing Competing Risk Data Using the R timereg PackageStatistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling.Serum sclerostin is an independent predictor of mortality in hemodialysis patientsFludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of thProspective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignanciesOne-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.Survival analysis in hematologic malignancies: recommendations for cliniciansPhase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantationSalvaged single-unit cord blood transplantation for 26 patients with hematologic malignancies not in remission.Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemiaThe effect of smoking on allogeneic transplant outcomes.Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.Assessing causal relationships between treatments and clinical outcomes: always read the fine print.Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients.Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.A case-cohort approach for multi-state models in hospital epidemiology.The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation.Initially fewer bloodstream infections for allogeneic vs. autologous stem-cell transplants in neutropenic patients.Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.Investigation of the freely available easy-to-use software 'EZR' for medical statistics.Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.CORR Insights(®): Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
P2860
Q23913313-C832B666-E543-493B-8B81-BE42BC42D225Q28607864-E60AFA97-EE84-4A4C-ACE8-BA5B73D54E04Q31019536-D1F21FD9-5707-45E7-834D-3C647A23F9E1Q31026869-CC327F4B-B5DF-4434-8E0A-9D04F63CD066Q33510698-69C2ABF6-F0E6-464A-98AB-0413B8A7314FQ33533445-C64C83E7-1BE2-40D4-810A-4EED2C2BC34EQ33886217-510361A0-E23E-4499-8889-083B480C9E9AQ33952823-0FB2FB7A-DE1D-4577-B459-C3FDD7EA2258Q34044024-16F58156-48A1-4553-8798-2597DC73A938Q34272525-47DD166D-7970-4C3F-BA86-501A19B95858Q34285987-78BDDBAB-7370-4F54-96AA-D83A253ADD42Q34307507-AF44C80B-E8D7-43B3-ADC0-D9BF70A7C98FQ34487398-B1B053BF-0484-487F-A899-942CD738611CQ34695045-0AA95E8C-F42F-42B4-A78E-BFB9C75A9085Q35142616-98F485B3-C4DD-4F51-9FED-AAEF952D7608Q35608181-422D1FDD-A6AE-4666-84C1-7EFBF3293A56Q35849045-A29C1473-F598-48AF-A2A4-151D77C2D3D4Q35945742-85E4F223-F267-49EB-8E53-1AFCFB7F7153Q35969119-2BB75A2C-CA07-4E6A-B948-7126A6933F9BQ36036279-4451151D-E044-4BD1-A984-D1AC7CE0FB32Q36176670-1930034A-6B79-42CF-BABA-393A2E99EFDFQ36196735-9E2F4D9D-023B-4F23-B50F-E09C575A5047Q36805898-60277874-75BD-453C-B85F-D7257E2AF71EQ37401674-3D0DBC54-9338-4C71-AFCB-11C69A464AE8Q37424438-CCAA98D0-A025-4C88-BA49-9769A3193021Q37592994-0ADDE2C1-0EE5-48E0-A8C8-35C6B49261B5Q37882393-C1B74517-9024-4B45-862B-4AA11E34032BQ38086718-24379334-AF0A-4E67-97EE-1C8D9D498B56Q38267184-65C72D11-0EC1-45BF-B958-57C8746A4B3AQ38955398-DF49E731-6CCE-4789-8F7A-35A6D0D65B73Q39256139-9FB6BC28-0936-49D5-8C56-47FA510E8EC9Q39544554-E9CE92B4-7131-4BBD-8145-FDF80E5508B2Q39644182-2838AC59-F105-4B53-B89D-B807399BF834Q39903954-8EDE8D0E-89E7-4103-9C3E-E40C8CA8EFD8Q40072430-D4302A35-C79B-4DAF-B662-509D4DEC8326Q41513106-7C15C9F2-D2BC-46BF-A2AB-F47071823146Q41549338-4B407F36-9F27-4CFA-873B-321462AFBD8EQ41681736-C00675AC-A93A-4605-9DF0-AB8283FD3AD2Q41688144-9799937F-64A9-43C1-97AF-881F133E25C6Q43169783-10680D90-26EA-45B3-B782-60439DB38A9D
P2860
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Statistical methods for the an ...... . Part I: unadjusted analysis.
@ast
Statistical methods for the an ...... . Part I: unadjusted analysis.
@en
Statistical methods for the an ...... . Part I: unadjusted analysis.
@nl
type
label
Statistical methods for the an ...... . Part I: unadjusted analysis.
@ast
Statistical methods for the an ...... . Part I: unadjusted analysis.
@en
Statistical methods for the an ...... . Part I: unadjusted analysis.
@nl
prefLabel
Statistical methods for the an ...... . Part I: unadjusted analysis.
@ast
Statistical methods for the an ...... . Part I: unadjusted analysis.
@en
Statistical methods for the an ...... . Part I: unadjusted analysis.
@nl
P2093
P2860
P356
P1476
Statistical methods for the an ...... . Part I: unadjusted analysis.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703260
P407
P577
2001-11-01T00:00:00Z
P5875
P6179
1052975863